Synthetic Biologics’ Board of Directors Accepts Resignation of Long-Standing Founder and Board Member

Synthetic Biologics’ Board of Directors Accepts Resignation of Long-Standing Founder and Board Member

[PR Newswire] – ROCKVILLE, Md., Feb. 26, 2014 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, announced t more

View todays social media effects on SYN

View the latest stocks trending across Twitter. Click to view dashboard

See who Synthetic is hiring next, click here to view

Share this post